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Assessment of Osteoporosis Risk by NTx- A
Biochemical Marker
Dr Aysha Habib Khan
Chemical Pathology

The risk of osteoporosis depends largely upon the
peak bone mass acquired during early adulthood
against the rate of bone loss occurring later in life. A
poor intake of calcium and vitamin D, physical
inactivity and prolonged amenorrhea are among the
factors that can severely diminish peak bone mass.
Females having low peak bone mass are more liable
to suffer from osteoporosis at the time of menopause.
A number of risk factors are known to be involved in
the pathogenesis of osteoporosis (table 1). The most
important risk factors include female gender,
Caucasian or Asian ethnicity, early menopause,
previous low trauma fracture, family history of
osteoporosis in first degree relatives, current
smoking and low body mass index. Additional
factors include chronic illness, endocrine disorders,
excessive alcohol intake and use of certain drugs
notably steroids. It is important to emphasise that
none of the risk factors predict bone mass with
sufficient accuracy in an individual patient. The best

combination of risk factors only accounts for about
20 per cent of the variability in bone mass. Clinical
risk factors thus add information about the risk of
osteoporosis, which is only partly explained by
variation in bone mass. They should therefore
preferably be used to target individuals for further
investigations (which include bone densitometry
and biochemical markers of bone turnover), and
treatment (table 2).
The definition of osteoporosis is based on bone
densitometry. Normal bone mass is defined as a bone
mineral density (BMD) above or below 1 SD from
the premenopausal mean value. Osteopenia is BMD
between -1SD and -2.5 SD while osteoporosis is
BMD below -2.5 SD. These criteria reflect the fact
that bone mass accounts for 75-85 per cent of the
variability in ultimate bone strength, it is considered
as one of the best single predictors of fracture risk
and low bone mass is an important risk factor for
osteoporosis.

Table 1: Risk Factor of Osteoporosis
Age
Previous fragility fracture
Endocrine
·
Premature menopause
·
BMI < 20
·
Previous Ammenorrhea (> 6 months duration)
Genetics
·
Low trauma fracture in first degree relative
·
Caucasian or Asian ethnicity
·
Female gender
Lifestyle
·
·
·
·
2

Low level of physical activity
Poor calcium intake (< 0.5 g/day)
Alcohol excess (> 14 units/week)
Cigarette smoking
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Table 2: Use of Risk Factors in Management
Target individuals for further investigation
·
Densitometry
·
Bone turnover markers
Eliminate modifiable risk factors
Discuss Treatment
·
Advantages
·
Disadvantages
Low bone mass together with a high rate of bone loss
further increases the risk of fracture. High bone
turnover as estimated by biochemical markers is
associated with an increased rate of bone loss and
predicts the risk of fracture independently of BMD.
Studies have reported odds ratio for fracture of
around 2 per 2 SD increase in the biochemical
marker above the premenopausal mean value. In
these studies, the biochemical markers with the best
predictive accuracy were urine C- and Ntelopeptides of type I collagen and urine deoxy
pyridinoline, all known to be biochemical markers of
bone resorption.
It is significant that a bone mass in the osteoporotic
range and an increased value of a biochemical
marker increase the odds ratio for hip fracture to 4-5,

suggesting that combined information on bone
densitometry and biochemical markers improves the
estimation of osteoporosis risk.
The biochemical marker of bone turnover that we
have introduced in our laboratory is N-terminal
telopeptide of type I collagen (NTx). It is measured
by a competitive-inhibition enzyme-linked
immunosorbent assay. Studies support the use of
NTx to monitor the anti-resorptive effect of therapy
and to determine the probability for a decrease in
BMD if therapy is not initiated. The
recommendation for monitoring therapy is to have
baseline samples just prior to or on the day of therapy
initiation. Subsequent specimens for comparison
should be collected at approximately the same time
of day as the baseline specimen.

Antibodies Against Cyclic Citrullinated
Peptides (Anti-CCP) Assay in Rheumatoid
Arthritis
Ms Shahmina Sadaf
Haematology
Rheumatoid arthritis (RA) is one of the most
common autoimmune diseases, affecting 0.5-1 per
cent of the world population. This systemic disease is
characterised by chronic inflammation of the
synovial joints and progressive joint degeneration
causing pain, joint destruction and impaired joint
mobility and eventually leading to loss of function
and disability of the affected individuals. Figure 1
shows differences between a healthy and damaged
joint. Early and aggressive intervention with new
and effective biological and targeted treatments can
3

alter the course of the disease and improve overall
quality of life. This suggests that improved markers
for diagnosis and prognosis are needed to identify
these patients at an earlier stage and modify the
available therapeutic choices according to the
individual patient's needs.
The diagnosis of RA often relies on clinical
manifestations and laboratory tests such as
erythrocyte sedimentation rate (ESR), rheumatoid
factor (RA-Factor) and C-reactive protein (CRP).
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However, RA-Factor is a non-specific marker and
may be present in healthy persons or in patients with
other autoimmune and infectious diseases while
CRP is a non-specific inflammatory marker. A new
laboratory test for diagnosing RA by measuring
antibodies against cyclic citrullinated peptides (antiCCP) has recently become available.
Anti-CCP is a quantitative determination of human
IgG autoantibodies against cyclic citrullinated
peptides in the human serum. It involves the IgG
capture principle by utilising the electrochemiluminescence methodology on fully
automated immunoassay analysers
(Figure 2). The assay has the sensitivity of
67.4 per cent and specificity 97.0 per cent
using a cut-off of 17 U/mL.
The antibodies are directed against the
circular peptide containing an amino acid
called citrulline. Citrullination refers to
the post-translational modification of the
amino acid arginine to citrulline by the
enzyme peptidylarginine deiminase
(PAD). The physiologic role of
citrullination is unclear; however it has
been shown to occur during apoptosis,
and is thought to play a role in the
degradation of intracellular proteins by
unfolding protein molecules and thereby
exposing them to degradation enzymes.
PAD enzymes can be found in monocytes
and macrophages associated with
inflammation, mostly in the synovial
fluid of patients with RA. Anti-CCP,
which is found in the serum, is thought to
be a result of diffusion of these antibodies
from the synovial fluid into the general
circulation

window of opportunity before irreversible damage
occurs, such a biomarker may be very useful when
used in combination with other clinical, radiological
and laboratory diagnostic features.
American College of Rheumatology, recommends
the use of anti-CCP assay as it is a sensitive and more
specific test than RA-Factor in early as well as fully
established disease. It also predicts the eventual
development into RA when found in undifferentiated
arthritis. It is a marker of erosive disease in RA and
may be detected in healthy individuals" years before
the onset of clinical RA.

Figure 1: Comparison of a healthy and damaged joint as seen in rheumatoid arthritis

Anti CCP-2 antibodies are more
promising as a diagnostic marker of RA
and can be used for the diagnosis of early
RA, prediction of disease severity,
differentiating RA from other forms of
non-RA inflammatory or arthritic
diseases and assessing treatment efficacy.
Anti-CCP antibodies have been
implicated in RA pathogenesis and hold
promise for the earlier and more accurate
diagnosis of RA, and improved
prognostic information. If the physician is
to intervene optimally during a patient's
4

Figure 2: Principle of anti-CCP assay in an automated immunoassay analyser
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A Disintegrin and Metallopeptidase with
Thrombospondin Type 1 Motif, 13
(ADAMTS-13)
Dr Farheen Karim Mahar
Haemataology
ADAMTS-13 is an enzyme which is released
primarily from the stellate cells of liver but is also
expressed in platelets and endothelial cells. It is
involved in the regulation of the size of von
willebrand factor (vWF) in the plasma. ADAMTS13 maintains primary haemostasis by proteolysing
ultra-large von Willebrand Factor (ULvWF). The
latter is the hyperactive form of vWF which is
released from storage granules (Weibel-Palade
bodies) of endothelial cells in response to
inflammatory stimulation. The ULvWF has more
affinity for platelets favouring platelet aggregation at
sites of high shear stress with subsequent formation
of micro vascular thrombi. The ULvWF relies upon
ADAMTS-13 for its cleavage and its conversion into
a less active form.
Deficiency of ADAMTS-13 may be congenital
(Upshaw-schulman syndrome) or much more
frequently acquired. An acquired deficiency is
attributed to the presence of auto-antibodies against
ADAMTS-13 which may either inhibit ADAMTS13 function or may cause rapid clearance of
circulating ADAMTS-13. Inherited or acquired
deficiency of ADAMTS-13 impairs ULvWF
cleavage. Deficient proteolysis of ULvWF results in
disseminated platelet-rich thrombi in the
microcirculation which in turn cause typical
thrombotic micro-angiopathies resulting in end
organ ischemia.
The laboratory assessment of ADAMTS-13 levels is
useful since severe deficiency of ADAMTS-13 has
been proposed as a specific laboratory marker of
thrombotic thrombocytopenic purpura (TTP) or
Upshaw-schulman syndrome. It is also seen in
conditions like sepsis, disseminated intravascular
coagulation (DIC) and metastatic malignancy. Mild
to moderate deficiency is seen in chronic
inflammation, hepatic dysfunction and pregnancy.
Given that severe secondary deficiency of
ADAMTS-13 might correlate with development of
5

widespread microvascular thrombi and end organ
injury, determination of ADAMTS-13 activity at the
time of hospital admission in patients with severe
conditions like sepsis and DIC will help in
understanding the extent of the disease. It also raises
the possibility of novel supportive therapies for
patients with sepsis and DIC such as ADAMTS-13
supplementation and plasma therapy because sepsis
may have the same pathophysiology of severe
ADAMTS-13 deficiency for thrombotic
microangiopathies as idiopathic TTP.
The test is currently offered by clinical laboratories
of AKUH. It is based on the principle of ELISA
technique. Two to three mls of blood collected in
citrate anticoagulant will be required for the test.
The reference range developed at AKUH for
ADAMTS-13 is 175-365 ng/dl. There is no
difference in reference range between males and
females or adults and children.
References:
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Soluble Transferrin Receptor (sTfR)
Dr Muhammad Shariq Shaikh
Haematology
Anaemia associated with chronic disease and iron
deficiency comprises the major bulk of all anaemias.
Differentiation between these two types of anaemias
and diagnosis of a patient with chronic disease
having iron deficiency is not very simple as they tend
to present with similar clinical and laboratory
features. In recent years, soluble transferrin receptor
(sTfR) and its ratio to ferritin (sTfR/ferritin) have
been proposed as useful tools in this regard.
The uptake of iron by cells is mediated by a
transferrin receptor (TfR) expressed on their external
surface. TfR binds diferric transferrin, and the
receptor-transferrin complex is internalised into an
endosome, where the iron is transferred to the
cytosol (Figure 1). After recycling to the cell surface,
the apo-transferrin dissociates, and the receptor is
free to repeat the process. Cells deficient in iron upregulate their expression of TfR to compete more
successfully for available iron. TfR is a disulfidelinked dimer of two identical 85-kDa subunits. Each
subunit has a 61-amino acid N-terminal cytoplasmic
domain, a transmembrane region, and a large
extracellular domain. TfR is shed from cells by
proteolytic cleavage just external to the plasma
membrane and just after the two interchain disulfide
bonds. The product circulates in the blood as soluble
TfR (sTfR), a 74-kDa monomer bound to transferrin.
The amount of circulating sTfR is proportional to the
total amount of cell-associated TfR.
The cellular need for more iron causes increased
expression of TfR, regulated by a mechanism
involving Iron-Responsive Elements (IRE) of
mRNA and Iron-Binding Proteins (IBP). IBPs
change conformation on binding iron; the iron-free
conformation binds to IREs, modifying mRNA in
ways that depend on the location of the IRE. In the
case of TfR mRNA, binding of IBPs stabilizes the
mRNA, thereby increasing the steady-state
concentration and increasing the rate of synthesis of
TfR. Thus, a low concentration of intracellular iron
leads to increased expression of TfR.
Since most cellular iron utilisation (80 per cent of
metabolic iron) is by erythroid precursor cells,
circulating sTfR is proportional to erythroid
6

precursor mass (i.e., rate of erythropoiesis). As a
consequence, sTfR is low in patients with
hypoplastic anaemias, and high in patients with
hyperplastic anaemias such as RBC haemolysis or
chronic blood loss. Similarly, plasma sTfR is high in
patients who are iron deficient and therefore
concentration of serum sTfR is useful in the
diagnosis of iron deficiency, especially in patients
with chronic inflammatory, infectious, or malignant
disease, where the usual tests of iron status may be
misleading.

Figure 1: Schematic mechanism for the uptake of iron by a cell.
TfR expressed on the cell surface preferentially binds Transferrin (Tf)
that has two atoms of iron. The Tf-TfR complex is internalized into
endosomes. The pH of endosomes decreases, facilitationg iron
dissociation and increasing the affinity of the receptor for apoTf.
The iron moves to the cytosol, and the endosome recycles to the
plasma membrane with the Tf-TfR complex. At the higher pH of the
extracellular fluid, apo-Tf dissociates and is replaced by diferric Tf,
and the cycle repeats.

It has been established that serum or plasma sTfR is
elevated by iron deficiency in patients with or
without chronic disease but is not affected by chronic
disease in the absence of iron deficiency. In many
clinical trials, it has been demonstrated that elevated
sTfR highly correlated with absence of iron in a
marrow aspirate, is the "gold standard" of iron
deficiency.
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At AKUH the test is performed by
immunoturbidimetric method on Roche Hitachi 902
method. The assay operates on the quantitative twosite immunoenzymometric (sandwich) technique. A
monoclonal antibody specific for sTfR is pre-coated
onto the wells of a micro plate. After the addition of
sample and assay diluents to the wells, it is incubated
for one hour, during which sTfR becomes bound to
the immobilised antibody. After any unbound
material is washed away, a second monoclonal
antibody conjugated to horseradish peroxidase is
added and incubated for one hour, during which the
conjugate binds to the captured sTfR. After another
washing away of unbound material, the amount of
bound conjugate is detected by reaction for 30
minutes with a specific substrate, which yields a
coloured product that is proportional to the amount
of conjugate (and thus to the amount of sTfR in the
sample). The colour reaction is stopped with
hydrochloric acid, and the concentration of sTfR in
each well is read from a calibration curve.

In addition to diagnosis of iron deficiency, serum
sTfR has been used to monitor the rate of
erythropoiesis. It has been used to follow marrow
engraftment after bone marrow transplant and to
categories anaemia as either hyperplastic or
hypoplastic.
References:
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Diagnosis of Cryptococcal Meningitis
Dr Kauser Jabeen
Microbiology
Cryptococcus neoformans is encapsulated
yeast that is responsible for serious infections
in immunocompromised population. The
common predisposing factors include AIDS,
prolonged treatment with steroids, organ
transplantation, advanced malignancy,
diabetes and sarcoidosis. Lungs and the CNS
are the most frequently involved sites;
however any organ can be involved in a
severely immuno-suppressed host. Accurate
management of this infection requires a high
index of suspicion and prompt diagnosis.
Diagnostic Modalities
Microscopic examination by India ink: It
is a rapid, cheap and effective method for
diagnosis of Cryptococcal infections.
Samples are mixed with a drop of India ink on
a glass slide and visualised under the
microscope. The microscopic examination is
positive in around 80 per cent of HIV and
50 per cent of non-HIV patients. Yeast could
be confused with lymphocytes surrounded
7

Figure 1: India ink preparation of CSF of a patient with meningitis
showing multiple encapsulated yeasts with budding (white arrow).
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by proteinaceous material. Therefore it is always
important to visualise budding yeast cells (figure 1).
On Gram staining Cryptococcus are visualised as
poorly-stained Gram positive yeasts.
Histology: Tissue biopsies and cytologies both are
very helpful in the diagnosis of
cryptococcosis. Cryptococcus
are visualised in routine
hematoxylin and eosin (H&E)
stain as round yeast cells
surrounded by empty spaces
(figure 2). The capsule could
be stained using mucicarmine
and alcian blue stain. Gomori's
methenamine silver (GMS)
stain could also be used to
visualise this narrow-based
budding yeast in the tissue.
Culture:
Cryptococcus
neoformans could grow on
most routine bacterial and
fungal media. This yeast
usually grows within 3-7 days
after inoculation of specimen
on the media. Most of the
isolates are positive for rapid
urease test. Final identification
is usually performed
biochemically on API yeast.
DNA-based methods could
also be performed to identify
the isolate.
Latex particle agglutination:
This test detects the presence
of the polysaccharide capsule
of the organism in the serum
and CSF (figure 3). It is a rapid
and extremely accurate test for
the diagnosis of Cryptococcal
infections. It has a sensitivity
and specificity of greater than
90 per cent. An additional
advantage of this test is the
reporting of polysaccharide
antigen titer. This information
could be used as a general
prognostic indicator as a high
titer of 1:1024 reflects greater
chance of therapeutic failure.
However it should be noted
8

that these titers should not be used to make
therapeutic decisions and the serial polysaccharide
antigen titers are often imprecise.
All of the above modalities for the diagnosis of
Cryptococcal infections are available at the clinical
microbiology laboratory of Aga Khan University.

Figure 2: Histology of lung of a patient showing multiple pink rounded yeast cells with empty spaces
suggestive of Cryptococcal infection

Figure3: Latex particle agglutination test for the detection of Cryptococcal capsular antigen.
Well 5 is showing a positive test with positive and negative controls in Well 1 and 2 respectively.
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Infections in Thalassaemia
Dr Sadia Omer
Microbiology
Thalassaemia is a heterogeneous group of genetic
disorders of hemoglobin synthesis characterised by
a disturbance in the production of globin chains,
leading to anaemia, ineffective erythropoiesis, and
premature destruction of red blood cells.
Clinical severity varies widely ranging from
asymptomatic forms to severe or even fatal entities.
In the severe forms of thalassaemia such as,
Cooley's anaemia or thalassaemia major, the
abnormal red blood cells processed by the spleen
and its haematopoietic response to the anaemia lead
to massive splenomegaly and consequent
manifestations of hypersplenism, ultimately
requiring splenectomy.
Infections are the predominant cause of death in
these patients accounting for 12-46 per cent of
overall patient deaths. It is estimated that about
9,000 children with beta thalassaemia are born
every year, although no documentary registry is
available in Pakistan. The estimated carrier rate is 57 per cent, accounting for 9.8 million carriers in the
total population.
Factors predisposing to infections in these
patients include:
1. Immune abnormalities in thalassaemic
patients including increased number and activity of
CD8 suppressor cells, decreased CD4/CD8 ratio,
C3 and C4 levels along with defective neutrophils,
macrophages and natural killer cell function.
2. Splenectomy-induced immune abnormalities
including reduced immune clearance along with
lower specific antibody responses.
3. Iron overload and bacterial infections:
Microbial pathogens must obtain growth-essential
iron from healthy hosts. Some potential pathogens
however are more dangerous in hosts with iron
overload. Iron overload causes decreased
phagocytosis by the monocyte/macrophage system
and polymorphonuclear leucocytes due to the
deleterious effects of ferritin associated with iron
and impairment in immunoglobulin secretion along
with suppression of complement system function.
9

Organisms such as Yersinia enterocolitica,
Klebsiella species, Escherichia coli, Streptococcus
pneumoniae, Pseudomonas aeruginosa, Listeria
monocytogenes, and Legionella pneumophila have
increased virulence in vitro in the presence of excess
iron. Iron overload can also have adverse effects on
the outcome of viral infections.
U n f o r t u n a t e l y, d e s f e r r i o x a m i n e t h e r a p y
predisposes to infections by Yersinia spp. The
virulence enhancing effect of desferrioxamine is
caused by either due to FoxA receptor that acts as a
receptor for its active metabolite too or due to its
partial immunosuppressant effect. Furthermore the
rate of progression of HIV-1 disease is faster in
patients with thalassaemia major on low doses of
desferrioxamine and high serum ferritin
concentrations and with high bone marrow
macrophage iron.
Specific infectious agents involved in infection
include:
Yersinia enterocolitica: Y.enterocolitica is an
uncommon cause of severe infections in
thalassaemic patients in the East unlike the West.
Y. enterocolitica has been associated with
septicemia, mesenteric lymphadenitis, liver and
splenic abscesses, and an acute appendicitis like
syndrome in these patients.
Microbiologic culture remains the standard for
diagnosis of yersiniosis. Stool is the preferred
clinical specimen for patients with intestinal
symptoms. Other specimens which should be
considered for culture include blood, throat,
wounds, and specimens obtained at surgery such as
the appendix or lymph nodes. Serologic tests are
also widely used for the diagnosis of yersiniosis.
Klebsiella spp: High ferritin level and deranged
liver function in thalassaemia appears to be the risk
factors of infections due to Klebsiella spp. The
diagnosis of K. pneumoniae infection is confirmed
by culture of blood, sputum, urine, or aspirated body
fluid.
Klebsiella spp. typically appears as short, plump,
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gram-negative bacilli, which are usually
surrounded by a capsule that appears as a clear space.
They have no specific growth requirement and
could grow on ordinary media. They are lactose
fermenters and this property is used for
identification in microbiology laboratories.
Salmonella spp.: Salmonellae are motile Gramnegative bacilli. Salmonella are oxidase negative
and virtually all are non-lactose fermenters. Most
laboratories identify Salmonellae by a combination
of antigenic and biochemical reactions. Suspicious
colonies are agglutinated using antisera directed
against specific O (lipopolysaccharide) and H
(flagellar) antigens that allow identification of the
serogroup
Escherichia coli: E. coli is Gram-negative,
facultative anaerobic, non lactose fermenters and
non-sporulating bacilli. Typically diagnosis is done
by culturing on MacConkey medium and
biochemical reactions. Other methods for detecting
E. coli include ELISA tests, colony immunoblots,
and direct immunofluorescence microscopy of
filters, immunocapture techniques and PCR.

Figure 1: Lancet-shaped gram positive diplococci suggestive of
Streptococcus pneumonia in a sputum smear

Effective vaccines are available against each of these
pathogens. It is mandatory for every patient
undergoing elective splenectomy to have
Pneumovax, optimally at about 1 month pre-surgery.
In addition to this immunoprophylaxis other
measures include chemoprophylaxis with prolonged
use of antibiotics and patient education to attend
seriously to any impending fever or infection.
Hepatitis B and C virus

Post-splenectomy infections: The incidence of
severe infections (for example, meningitis,
pneumonia, sepsis) caused by encapsulated bacteria
(S pneumoniae, H influenzae type B, N
meningitidis) is six per cent higher among
splenectomised patients with thalassaemia
compared with those individuals splenectomised
for trauma. Children appear to be at particularly
high risk. Other pathogens responsible for postsplenectomy infections include bacteria such as E
coli, P aeruginosa, group B beta hemolytic
streptococci, Enterococcus spp, Ehrlichia spp, and
Plasmodium spp. Blood culture is routinely done for
the diagnosis of these infections. Several rapid
diagnostic tests have been developed to aid in the
diagnosis along with PCR.
Streptococcus pneumoniae has characteristic
lancet-shaped gram positive diplococci. Like
Klebsiella spp., they have no specific growth
requirement. Complementary method to detect
S.pneumoniae is urinary antigen assays. The test has
high sensitivity compared to blood cultures and
sputum studies in patients with bacteremia. Other
tests including PCR tests for detecting
pneumococcal autolysin or pneumolysin have been
developed.

10

Hepatitis B (HBV) and C virus (HCV) infections are
a major problem for thalassaemic patients because of
repeated blood transfusions. Infection with these
blood borne viruses is associated with characteristic
changes in the serum levels of viral antigens and
antibodies. Diagnostic qualitative and quantitative
PCR tests for HBV and HCV in serum have been
developed to assess in diagnosing viral replication.
The availability of vaccines and the introduction of
the screening of transfused blood units for hepatitis
Bs antigen (HBsAg) and HCV antibodies have
reduced the incidence of these infections.
Malaria and á-thalassaemia
Both á-and â- thalassaemia have been shown to
afford some protection against P. falciparum malaria
in keeping with their geographical distribution, but
the mechanism of protection remains unknown.
However in case of infection, detection of parasites
on Giemsa-stained blood smears by light
microscopy remains the gold standard for diagnosis
of malaria. Rapid diagnostic tests for detection of
Plasmodium spp. have been developed. However
desirable characteristics for RDTs vary depending
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on the epidemiology of infection and goals for
control in the region where the test is used.
Molecular technologies are also emerging in
assisting the diagnosis of malaria.

Early recognition with prompt treatment and
prevention of predisposing factors are essential in
the treatment of patients with thalassaemia and
infection.

CDX-2, A Reliable Diagnostic Marker for
Carcinomas of Colorectal Origin
Dr Arsalan Ahmed and Dr M. Abrar Barakzai
Histopathology

CDX-2 is a caudal-related homeobox transcription
factor whose expression in adults is normally
restricted to the intestinal epithelium. CDX-2 protein
is responsible for regulating the proliferation and
differentiation of intestinal epithelial cells and
therefore it is expressed predominantly, as a nuclear
marker of epithelial cells, lining the villi and crypts
in the small and large intestines. Hence, CDX-2
protein is a useful marker for intestinal
adenocarcinomas,
especially
colorectal
adenocarcinomas.
The differentiation of secondary from primary
adenocarcinomas of the colorectum is important
because their clinical management and prognosis are
different. CDX-2 immunostaining may be useful in
discriminating primary and metastatic colorectal
carcinomas from frequent types of adenocarcinomas
of nongastrointestinal origin, since CDX-2 is
consistently expressed in more than 90 per
cent of colorectal carcinomas, while its
expression is rare in extraintestinal
adenocarcinomass like breast, lung, thyroid,
kidney and endometrial adenocarcinomas.
However, CDX-2 is expressed in 10-30 per
cent of other gastrointestinal malignancies,
20-65 per cent of mucinous ovarian tumors
and 50-100 per cent of urinary bladder
carcinomas. Compared with villin, a
previously described marker of
gastrointestinal adenocarcinoma, CDX-2
demonstrates superior sensitivity and
comparable specificity.
Another important aspect of CDX-2
expression in colon carcinomas is that CDX-2
expression is inversely related to the degree of
anaplasia, therefore loss of CDX-2 protein
11

expression has been correlated with loss of
differentiation in colorectal cancers and hence
poorly differentiated colorectal carcinomas
demonstrate a lower frequency of CDX-2 staining
compared to well and moderately differentiated
tumors. Thus, it may have both diagnostic and
prognostic uses.
CDX-2 is a reliable, specific, and sensitive
immunohistochemical marker of normal and
neoplastic intestinal epithelium and can be easily
applied to routine histologic and cytologic material.
It may have both diagnostic and prognostic uses,
suggesting including of CDX2 in any antibody panel
to distinguish between primary and secondary
epithelial colorectal malignancies, as well as
targeting metastasis from an unknown primary.
AKUH Laboratory has recently added this marker in
the immunohistochemistry panel.

Figure 1: Colorectal Carcinoma showing diffuse nuclear positivity to CDX-2
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Radiopaque Metallic Marker Insertion in
Breast Cancers Prior to Neoadjuvant/
Preoperative Chemotherapy
Dr Shaista Afzal, Dr Gulnaz Shafqat, Dr Imrana Masroor
Radiology
Over the last two decades neoadjuvant chemotherapy or
hormonal manipulation has been increasingly used as a
treatment option in the management of patients with large
operable breast cancer. The advantage of neoadjuvant
chemotherapy over adjuvant chemotherapy is that large
cancers can be down-staged thereby increasing the possibility
of breast conserving surgery and the response to the treatment
can also be monitored. There are a number of studies which
have reported remarkable radiological and pathological
response with little or no residual tumor following the
treatment. Such excellent response creates problems in
localisation and excision of the residual tumor and so imposes
a challenge for accurate surgery. Complete response at
imaging does not necessarily implicate a complete
pathological response and it is not a safe practice to plan
surgery based on radiological findings alone. It is in these
cases that localisation of the tumor bed with radiopaque
markers prior to the institution of chemotherapy may
facilitate breast conservation surgery with complete excision
of tumor bed to ensure removal of microscopic disease.

Figure 1: Mammogram before the commencement of
neoadjuvant chemotherapy Showing the radiopaque clip

The procedure of radiopaque marker insertion is very simple
and can be carried out by a radiologist under mammographic
or ultrasound guidance. After routine prepping and local
anesthesia a 16-18 gauge lumbar puncture needle is inserted
into the lesion ideally in the centre and radiopaque metallic
clip is inserted and the trocar is used to push the marker in
position. After the insertion of the clip unilateral
mammogram is obtained to confirm the position of the marker
(figure 1)
On completion of chemotherapy (figure 2) the surgeons
reassess to determine the feasibility of breast conservation
surgery and if the tumor shows a complete response to
chemotherapy or is impalpable pre-operative guide wire
localisation for the metallic markers is carried out for marking
the tumor bed.
In summary implantation of radiopaque clips in or adjacent
to carcinoma of breast is useful in tagging the tumor bed prior
to breast conservation surgery, especially in patients with
complete radiological and clinical tumor regression
following neoadjuvant chemotherapy.
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Figure 2: Mammogram after the completion of
neoadjuvant chemotherapy Showing the radiopaque clip
and the tumour showing partial response
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Meeting Reports: 10TH International
Radiological Conference 2009
Dr Azieka Imdad, Muhammad Bilal Ahmad
Radiology
th

The 10 International Radiological Conference was
held from November 7-9, 2009 at the Sheraton Hotel
in Karachi. The theme of the conference was
'achieving excellence in radiology practice.' It was
organised by the Radiological Society of Pakistan
(RSP).

A workshop session on radiographic critique was
held at AKUH: it was organized for radiographers,
regarding quality control, emergency and trauma
radiography and radiation protection.

Participants from all over Pakistan as well as from
USA, UK, Canada and India attended the conference.
Papers presented during the conference covered a
diverse range of topics with discussion of recent
advancements and methods.

On day two, the pre-conference workshops were
continued and Multi-Detector CT (MDCT) as an
advanced imaging modality was discussed, during
the first session. It was focused on orienting the
participants about MDCT image formation, image
manipulation and contrast delivery. An
interpretation session followed the workshop.

Very informative and interactive pre-conference
workshops were arranged for the radiologists,
trainees and radiographers, covering many
important aspects of radiology training and
advancements. On day one several workshops were
held.

Hands-on practice was given to the participants
during Doppler and Musculoskeletal (MSK)
ultrasound workshop session, which focused on
the carotid, peripheral, renal and visceral Doppler,
as well as providing basic knowledge about MSK
ultrasound and interpretation.

A basic MRI course was held at the Sheraton hotel.
The chief organiser, Dr Zafar Sajjad, Associate
Professor and Interim Chair, Department of
Radiology, AKUH conducted it with excellence. It
focused on providing the participants about basic
knowledge of MRI physics, contrast usage and MR
imaging of the shoulder, knee, spine and brain.

A workshop on Breast imaging facilitated by
Dr Imrana Masroor, Associate Professor,
Department of Radiology, AKUH, and her team
highlighted on breast ultrasound, intervention and
MRI and mammograms. The workshop was
interactive and helped the participants to
understand the basics of breast imaging.

A hands-on workshop of obstetric/gynae ultrasound
was organised at Jinnah Post Graduate Medical
Center (JPMC). It was a very successful and helpful
workshop that allowed participating radiologists to
enhance their practical skills, regarding foetal
doppler ultrasound and placental evaluation.

A full-day workshop on Interventional Radiology
was held at AKUH; Dr Imran Syed, Consultant
Radiologist, from Queen's Hospital, UK
conducted the workshop and gave a live
demonstration of interventional procedures like
biliary interventions, Peripherally Inserted Central
Catheter (PICC) and central venous line placement
and Trans Arterial Chemoembolisation (TACE).
Hands-on was also given for US guided procedures.

Another useful pre-conference workshop showed
participants how to initiate a radiology research
project. Facilitated by Dr Wasim Akhtar, Assistant
Professor, Department of Radiology, AKUH, it was
very appreciated as a number of radiologists needed
guidance on the initiation of research projects. It
proved to enhance the basic know-how of the
participants about radiology research, literature
research, biostatistics and common errors in paper
writing.
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D r N a i l a N a d e e m , A s s i s t a n t P r o f e s s o r,
Department of Radiology, AKUH organised a
workshop on Assessment and feedback to trainees
during work in radiology. Its main focus was
assessment of radiology residents during training
and role of faculty and residents on feedback
system.
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The session of video conferencing between UK and
Pakistan was highly interactive and mainly focused
on the musculoskeletal imaging, also served as a
bridge between the Pakistani and the UK-based
Pakistani consultants.
AKUH radiology actively participated in the
conference and won prizes. The first prize for best
paper presentation was won by Dr Zainab Hussain,
Resident, Department of Radiology, AKUH while
the first prize for best poster was won by Mr Mansoor
Naqvi, Physicist, Department of Radiology, AKUH
and second prize by Dr Rana Shoaib, Fellow of
Radiology, Department of Radiology, AKUH. The
winners of the conference quiz were Dr Fahd Haroon
and Dr Mohammed Zeeshan, Resident, Department

of Radiology, AKUH who jointly received the first
prize.
Another highlight of the conference was the cultural
evening and banquet dinner held on November 9. It
was well attended and was very refreshing for the
participants of the conference, with music served as a
food for the soul.
The conference concluded on November 9 with the
distribution of certificates and souvenirs among the
organisers and participants. Efforts of scientific
committee were commendable under the leadership
of Dr Tanveer-ul-Haq who was fully supported by
president of the RSP, Dr. M. Nadeem Ahmad and
Dr Zafar Sajjad.

Continuing Medical Education Seminar
Organised by Clinical Laboratory at AKUH
Ms Seema Vaqar
On December 9, the Clinical Laboratory arranged a
Continuous Medical Education Seminar at AKU
auditorium on “Assessing and Managing
Osteoporosis”. It was the first time at AKU that this
CME was seen by all AKHSP via Elluminate Live!
The seminar was a unique experience and a
successful one as questions and answers were
exchanged between AKHSP audience and speakers.
Dr Farooq Ghani, Associate Professor and
Consultant Pathologist, Department
of Pathology & Microbiology,
AKUH, gave the opening statement
followed by a presentation by
Dr Aysha Habib Khan, Assistant
Professor and Consultant
Pathologist, Department of
Pathology and Microbiology,
AKUH, on osteoporosis and its
assessment. She highlighted the risk
factors leading to osteoporosis and
showed concerns about patients
with fractures not being evaluated
for osteoporosis. Dr Romaina Iqbal,
Assistant Professor and Consultant
Nutritionist, Department of
Community Health Sciences and
Medicine, AKUH, enlightened the
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audience about taking healthy food to avoid calcium
deficiency. Dr Jaweed Akhtar, Associate Professor
and Consultant Endocrinologist, Department of
Medicine, AKUH, talked about pharmacological
management of osteoporosis, and discussed
different therapies for osteoporosis with their pros
and cons. Mr Asim Mahmood, Physiotherapist,
Department of Physiotherapy, AKUH, emphasised
on different exercises which helps in correcting
postures.
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